Search

Your search keyword '"Esteves, Cecilia"' showing total 125 results

Search Constraints

Start Over You searched for: Author "Esteves, Cecilia" Remove constraint Author: "Esteves, Cecilia"
125 results on '"Esteves, Cecilia"'

Search Results

1. The Undiagnosed Diseases Network: Characteristics of solvable applicants and diagnostic suggestions for nonaccepted ones

2. A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder

3. Clinical application of a scale to assess genomic healthcare empowerment (GEmS): Process and illustrative case examples

4. Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections

5. Commonalities across computational workflows for uncovering explanatory variants in undiagnosed cases.

6. Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science.

7. Bi-allelic variants in INTS11 are associated with a complex neurological disorder

8. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

9. De Novo Pathogenic Variants in N-cadherin Cause a Syndromic Neurodevelopmental Disorder with Corpus Collosum, Axon, Cardiac, Ocular, and Genital Defects

10. Heterozygous variants in MYBPC1 are associated with an expanded neuromuscular phenotype beyond arthrogryposis

11. IgG4‐related disease: Association with a rare gene variant expressed in cytotoxic T cells

12. Bi-allelic Variants in TONSL Cause SPONASTRIME Dysplasia and a Spectrum of Skeletal Dysplasia Phenotypes

13. Effect of Genetic Diagnosis on Patients with Previously Undiagnosed Disease

14. IRF2BPL Is Associated with Neurological Phenotypes

15. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

16. Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11

17. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling

18. 86 Genome sequencing as a first-tier prenatal diagnostic test: Is it time to change?

19. Biallelic CRELD1 variants cause a multisystem syndrome including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections.

20. P780: Improving peripartum health is an unappreciated advantage of prenatal genome sequencing

21. O44: Genome sequencing as a first-tier prenatal diagnostic test

22. Bi-allelic variants in INTS11 are associated with a complex neurological disorder

23. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

24. Atypical Alexander disease with dystonia, retinopathy, and a brain mass mimicking astrocytoma

25. Correction to: Sequencing and curation strategies for identifying candidate glioblastoma treatments

26. Sequencing and curation strategies for identifying candidate glioblastoma treatments

27. The contribution of mosaicism to genetic diseases and de novo pathogenic variants.

31. Missense and truncating variants in CHD5 in a dominant neurodevelopmental disorder with intellectual disability, behavioral disturbances, and epilepsy

32. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

33. One is the loneliest number: genotypic matchmaking using the electronic health record

34. Correction to:An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids (Genetics in Medicine, (2021), 23, 4, (740-750), 10.1038/s41436-020-01027-3)

35. Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain

36. An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

37. The Undiagnosed Diseases Network: Characteristics of solvable applicants and diagnostic suggestions for nonaccepted ones

38. De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia

40. De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation

41. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling

42. Spectrum of neurodevelopmental disease associated with the GNAO1 guanosine triphosphate-binding region

43. Identification of rare-disease genes using blood transcriptome sequencing and large control cohorts

44. Finding commonalities in rare diseases through the undiagnosed diseases network.

45. Magnetic Resonance Imaging characteristics in case of TOR1AIP1 muscular dystrophy

46. De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia

47. Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification

48. Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay

49. A comprehensive iterative approach is highly effective in diagnosing individuals who are exome negative

50. Correction: Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

Catalog

Books, media, physical & digital resources